PCVX
Price
$33.46
Change
+$1.46 (+4.56%)
Updated
Jul 8 closing price
Capitalization
4.32B
34 days until earnings call
TSHA
Price
$2.42
Change
+$0.08 (+3.42%)
Updated
Jul 8 closing price
Capitalization
632.9M
40 days until earnings call
Interact to see
Advertisement

PCVX vs TSHA

Header iconPCVX vs TSHA Comparison
Open Charts PCVX vs TSHABanner chart's image
Vaxcyte
Price$33.46
Change+$1.46 (+4.56%)
Volume$1.6M
Capitalization4.32B
Taysha Gene Therapies
Price$2.42
Change+$0.08 (+3.42%)
Volume$2.31M
Capitalization632.9M
PCVX vs TSHA Comparison Chart in %
Loading...
PCVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TSHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PCVX vs. TSHA commentary
Jul 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PCVX is a Buy and TSHA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 09, 2025
Stock price -- (PCVX: $33.46 vs. TSHA: $2.42)
Brand notoriety: PCVX and TSHA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PCVX: 82% vs. TSHA: 55%
Market capitalization -- PCVX: $4.32B vs. TSHA: $632.9M
PCVX [@Biotechnology] is valued at $4.32B. TSHA’s [@Biotechnology] market capitalization is $632.9M. The market cap for tickers in the [@Biotechnology] industry ranges from $309.49B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PCVX’s FA Score shows that 0 FA rating(s) are green whileTSHA’s FA Score has 0 green FA rating(s).

  • PCVX’s FA Score: 0 green, 5 red.
  • TSHA’s FA Score: 0 green, 5 red.
According to our system of comparison, PCVX is a better buy in the long-term than TSHA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PCVX’s TA Score shows that 6 TA indicator(s) are bullish while TSHA’s TA Score has 3 bullish TA indicator(s).

  • PCVX’s TA Score: 6 bullish, 2 bearish.
  • TSHA’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, PCVX is a better buy in the short-term than TSHA.

Price Growth

PCVX (@Biotechnology) experienced а +1.58% price change this week, while TSHA (@Biotechnology) price change was +3.42% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.39%. For the same industry, the average monthly price growth was +14.41%, and the average quarterly price growth was +12.94%.

Reported Earning Dates

PCVX is expected to report earnings on Nov 10, 2025.

TSHA is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Biotechnology (+9.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PCVX($4.32B) has a higher market cap than TSHA($633M). TSHA YTD gains are higher at: 39.884 vs. PCVX (-59.125). TSHA has higher annual earnings (EBITDA): -85.47M vs. PCVX (-512.62M). PCVX has more cash in the bank: 1.67B vs. TSHA (117M). TSHA has less debt than PCVX: TSHA (61.4M) vs PCVX (87.2M). TSHA has higher revenues than PCVX: TSHA (7.22M) vs PCVX (0).
PCVXTSHAPCVX / TSHA
Capitalization4.32B633M682%
EBITDA-512.62M-85.47M600%
Gain YTD-59.12539.884-148%
P/E RatioN/A2.70-
Revenue07.22M-
Total Cash1.67B117M1,429%
Total Debt87.2M61.4M142%
TECHNICAL ANALYSIS
Technical Analysis
PCVXTSHA
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
78%
Momentum
ODDS (%)
Bullish Trend 1 day ago
75%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
76%
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 8 days ago
80%
Bullish Trend 7 days ago
80%
Declines
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
PCVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TSHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JSMGX27.700.04
+0.14%
Janus Henderson Triton I
PHSTX54.75N/A
N/A
Putnam Global Health Care A
RYCNX43.06N/A
N/A
Rydex Transportation C
NMIAX27.97N/A
N/A
Columbia Large Cap Enhanced Core A
GTCEX28.28-0.02
-0.07%
Glenmede Strategic Equity

TSHA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TSHA has been loosely correlated with XNCR. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if TSHA jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TSHA
1D Price
Change %
TSHA100%
+3.42%
XNCR - TSHA
42%
Loosely correlated
+4.16%
ERAS - TSHA
42%
Loosely correlated
+2.82%
DNTH - TSHA
40%
Loosely correlated
N/A
SLDB - TSHA
40%
Loosely correlated
+6.72%
TRDA - TSHA
40%
Loosely correlated
+2.73%
More